Identification of a New Tumor Suppressor Gene Located at Chromosome 8p21.3-22
Overview
Affiliations
Transformation of normal cells into malignant tumor cells, a process termed carcinogenesis, depends on progressive acquisition of genetic alterations. These result in activation of protooncogenes or inactivation of tumor suppressor genes responsible for the loss of proliferative control in tumor cells and the failure to undergo cellular differentiation. The aim of our study was the identification of molecular regulators of carcinogenesis by studying gene expression during induction of cellular differentiation and quiescence in a three-dimensional (3D) cell culture model. Here, we report the discovery of a tumor suppressor gene located at chromosome 8p21.3-22 near marker D8S254. It is ubiquitously expressed in normal tissue and transiently up-regulated during initiation of cellular differentiation and quiescence in 3D cell culture. In contrast, mRNA expression was not detectable in tissue from pancreatic tumor and the pancreatic tumor cell line MIA PaCa-2. Recombinant expression in the tumor cell line MIA PaCa-2 inhibited proliferation, as shown by a 30% reduction of BrdU uptake after recombinant expression. Immunocytochemistry and Western blot analysis of subcellular fractions demonstrated a mitochondrial localization for the mature protein. In conclusion, we identified a tumor suppressor gene at chromosome 8p21.3-22, encoding a mitochondrial protein, controlling cellular proliferation.
Tang D, Cao C, Li W, Wang A BMC Cancer. 2024; 24(1):1489.
PMID: 39627705 PMC: 11613461. DOI: 10.1186/s12885-024-13253-y.
Wang H, Diao Y, Tan P, Liang H World J Gastrointest Oncol. 2024; 16(5):1908-1924.
PMID: 38764831 PMC: 11099447. DOI: 10.4251/wjgo.v16.i5.1908.
Tang D, Zhao L, Huang S, Li W, He Q, Wang A Int J Biol Sci. 2024; 20(7):2576-2591.
PMID: 38725862 PMC: 11077360. DOI: 10.7150/ijbs.94795.
The Angiotensin AT Receptor: From a Binding Site to a Novel Therapeutic Target.
Steckelings U, Widdop R, Sturrock E, Lubbe L, Hussain T, Kaschina E Pharmacol Rev. 2022; 74(4):1051-1135.
PMID: 36180112 PMC: 9553111. DOI: 10.1124/pharmrev.120.000281.
SCARA3 inhibits cell proliferation and EMT through AKT signaling pathway in lung cancer.
Kim J, You H, Youn C BMC Cancer. 2022; 22(1):552.
PMID: 35578316 PMC: 9112459. DOI: 10.1186/s12885-022-09631-z.